JNJ-64417184

· Janssen Research & Development, LLC

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for JNJ-64417184, covering 2025-02-03 to 2025-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Interaction Between JNJ-64417184 and JNJ-53718678 After Single and Multiple Dosing in Healthy Participants [Phase 1]

See pricing